To amend the Patient Protection and Affordable Care Act to ensure that taxpayer funds for health insurance coverage are available only to authorized individuals, and for other purposes.

HR7817 amends the Patient Protection and Affordable Care Act (ACA) to explicitly prevent federal funds, specifically those provided to states under Section 1332, from being used to offset health insurance costs for individuals who are not citizens, nationals, or lawfully present aliens. This means individuals without legal status will no longer receive premium or cost-sharing reductions through state-run ACA programs. The bill also mandates the rescission of any existing waivers that contradict these new provisions within 30 days of enactment. This action immediately reduces the total addressable market for subsidized health insurance plans. The money trail for this bill is a reduction in federal outlays. Federal funds previously allocated to states, which could have indirectly supported health insurance for unauthorized individuals through broad waiver programs, will now be explicitly restricted. This does not redirect funds to specific companies but rather reduces the overall subsidy pool. Health insurance companies that participate heavily in ACA marketplace plans, such as UnitedHealth Group ($UNH), Elevance Health, Humana ($HUM), Centene ($CNC), and Molina Healthcare ($MOH), will experience a reduction in potential enrollees who receive federal subsidies, leading to lower premium revenue from this specific demographic. Historically, legislative actions that restrict eligibility for federal healthcare subsidies have led to a contraction in the insured population and, consequently, a reduction in revenue for health insurers. For example, during attempts to repeal and replace the ACA in 2017, health insurance stocks experienced volatility. While direct historical precedent for this specific type of eligibility restriction is limited, any policy that reduces the number of subsidized enrollees negatively impacts insurers' top lines. The Congressional Budget Office (CBO) has consistently projected that reducing subsidy eligibility leads to fewer insured individuals and lower federal spending, which translates to less revenue for insurers. Specific losers are health insurance providers with significant exposure to ACA marketplace plans. These include UnitedHealth Group ($UNH), Elevance Health, Humana ($HUM), Centene ($CNC), and Molina Healthcare ($MOH). These companies benefit from a larger pool of subsidized enrollees, and this bill directly shrinks that pool. There are no clear winners from this legislation, as it primarily involves a reduction in federal spending and a contraction of the subsidized insurance market. The bill's referral to two committees indicates it is in the early stages of the legislative process. Its passage is not guaranteed, but if it moves forward, the impact on these insurers will become more pronounced. The timeline involves initial committee consideration. As a bill introduced by a junior member with 14 cosponsors, its immediate legislative momentum is moderate. However, if it gains traction, the next steps would be committee hearings, markups, and potentially a floor vote. The 30-day rescission clause for waivers would take effect immediately upon enactment, leading to a rapid adjustment in state-level subsidy programs and a corresponding impact on insurer enrollment figures.